Yeh, Robert W

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 10.

Kelbæk, Henning; Yeh, Robert W; Engstrøm, Thomas; Neumann, Franz-Josef; Serruys, Patrick W; Windecker, Stephan; Belardi, Jorge; Qiao, Shubin; Xu, Bo; Liu, Minglei; Silber, Sigmund (2019). Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions. (In Press). EuroIntervention Europa Digital & Publishing 10.4244/EIJ-D-19-00866

Urban, Philip; Mehran, Roxana; Colleran, Roisin; Angiolillo, Dominick J; Byrne, Robert A; Capodanno, Davide; Cuisset, Thomas; Cutlip, Donald; Eerdmans, Pedro; Eikelboom, John; Farb, Andrew; Gibson, C Michael; Gregson, John; Haude, Michael; James, Stefan K; Kim, Hyo-Soo; Kimura, Takeshi; Konishi, Akihide; Laschinger, John; Leon, Martin B; ... (2019). Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. European heart journal, 40(31), pp. 2632-2653. Oxford University Press 10.1093/eurheartj/ehz372

Urban, Philip; Mehran, Roxana; Colleran, Roisin; Angiolillo, Dominick J; Byrne, Robert A; Capodanno, Davide; Cuisset, Thomas; Cutlip, Donald; Eerdmans, Pedro; Eikelboom, John; Farb, Andrew; Gibson, C Michael; Gregson, John; Haude, Michael; James, Stefan K; Kim, Hyo-Soo; Kimura, Takeshi; Konishi, Akihide; Laschinger, John; Leon, Martin B; ... (2019). Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk. Circulation, 140(3), pp. 240-261. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.119.040167

Mauri, Laura; Kirtane, Ajay J; Windecker, Stephan; Yeh, Robert W; Dauerman, Harold L; Price, Matthew J; Christen, Thomas; Allocco, Dominic J; Meredith, Ian T; Kereiakes, Dean J (2018). Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention. American Heart Journal, 205, pp. 110-117. Elsevier 10.1016/j.ahj.2018.08.004

Hermiller, James B; Krucoff, Mitchell W; Kereiakes, Dean J; Windecker, Stephan; Steg, P Gabriel; Yeh, Robert W; Cohen, David J; Cutlip, Donald E; Massaro, Joseph M; Hsieh, Wen-Hua; Mauri, Laura (2016). Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC. Cardiovascular Interventions, 9(2), pp. 138-147. Elsevier 10.1016/j.jcin.2015.10.001

Mauri, Laura; Elmariah, Sammy; Yeh, Robert W; Cutlip, Donald E; Steg, P Gabriel; Windecker, Stephan; Wiviott, Stephen D; Cohen, David J; Massaro, Joseph M; D'Agostino, Ralph B; Braunwald, Eugene; Kereiakes, Dean J (2016). Causes of late mortality with dual antiplatelet therapy after coronary stents. European Heart Journal, 37(4), pp. 378-385. Oxford University Press 10.1093/eurheartj/ehv614

Kereiakes, Dean J; Yeh, Robert W; Massaro, Joseph M; Driscoll-Shempp, Priscilla; Cutlip, Donald E; Steg, P Gabriel; Gershlick, Anthony H; Darius, Harald; Meredith, Ian T; Ormiston, John; Tanguay, Jean-François; Windecker, Stephan; Garratt, Kirk N; Kandzari, David E; Lee, David P; Simon, Daniel I; Iancu, Adrian Corneliu; Trebacz, Jaroslaw; Mauri, Laura (2015). Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC. Cardiovascular Interventions, 8(12), pp. 1552-1562. Elsevier 10.1016/j.jcin.2015.05.026

Yeh, Robert W; Kereiakes, Dean J; Steg, Philippe Gabriel; Windecker, Stephan; Rinaldi, Michael J; Gershlick, Anthony H; Cutlip, Donald E; Cohen, David J; Tanguay, Jean-Francois; Jacobs, Alice; Wiviott, Stephen D; Massaro, Joseph M; Iancu, Adrian C; Mauri, Laura (2015). Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. Journal of the American College of Cardiology, 65(20), pp. 2211-2221. Elsevier 10.1016/j.jacc.2015.03.003

Kereiakes, Dean J; Yeh, Robert W; Massaro, Joseph M; Driscoll-Shempp, Priscilla; Cutlip, Donald E; Steg, P Gabriel; Gershlick, Anthony H; Darius, Harald; Meredith, Ian T; Ormiston, John; Tanguay, Jean Francois; Windecker, Stephan; Garratt, Kirk N; Kandzari, David E; Lee, David P; Simon, Daniel I; Iancu, Adrian Corneliu; Trebacz, Jaroslaw; Mauri, Laura (2015). Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA : the journal of the American Medical Association, 313(11), pp. 1113-1121. American Medical Association 10.1001/jama.2015.1671

Mauri, Laura; Kereiakes, Dean J; Yeh, Robert W; Driscoll-Shempp, Priscilla; Cutlip, Donald E; Steg, P Gabriel; Normand, Sharon-Lise T; Braunwald, Eugene; Wiviott, Stephen D; Cohen, David J; Holmes, David R; Krucoff, Mitchell W; Hermiller, James; Dauerman, Harold L; Simon, Daniel I; Kandzari, David E; Garratt, Kirk N; Lee, David P; Pow, Thomas K; Ver Lee, Peter; ... (2014). Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. New England journal of medicine NEJM, 371(23), pp. 2155-2166. Massachusetts Medical Society MMS 10.1056/NEJMoa1409312

This list was generated on Fri Aug 7 15:17:31 2020 CEST.
Provide Feedback